(2015) Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
Highlights of Prescribing Information: Ozempic (semaglutide) injection, for subcutaneous use
People with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 should not use semaglutide, as animal studies raised theoretical concerns about thyroid safety in these populations
We observed that average 24-hour systolic BP was reduced significantly with tirzepatide compared with placebo, ranging from 7.4 to 10.6 mmHg reduction in the dose arms
Is infusion therapy worth it
To create your patient portal account, youll need to provide your full name, date of birth, email address, phone number, and mailing address